ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,156Medicare Part D Prescriptions Filled, Including Refills

Rank: 131 out of 783

$549K Total Retail Price of All Prescriptions

Rank: 224 out of 783

566 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 566 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 566 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 11,048 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 451 445 1 1
FUROSEMIDE 420 407 2 7
PRAVASTATIN SODIUM 389 364 3 14
LISINOPRIL 376 356 4 4
AMLODIPINE BESYLATE 345 341 5 5
ATENOLOL 295 295 6 17
SIMVASTATIN 256 238 7 3
HYDROCODONE-ACETAMINOPHEN 232 165 S3 8 2
HYDROCHLOROTHIAZIDE 222 196 9 12
OMEPRAZOLE 211 185 10 6
TRIAMTERENE-HCTZ 210 189 11 42
METFORMIN HCL 190 165 12 8
MELOXICAM 187 165 13 37
TRAZODONE HCL 179 141 14 39
METOPROLOL SUCCINATE 178 149 15 13
WARFARIN SODIUM 173 163 16 10
ATORVASTATIN CALCIUM 173 163 16 11
CITALOPRAM HBR 160 135 18 19
TRAMADOL HCL 159 133 19 20
LOVASTATIN 155 155 20 58
GABAPENTIN 137 104 21 15
DONEPEZIL HCL 130 130 22 24
POTASSIUM CHLORIDE 128 125 23 16
FLUTICASONE PROPIONATE 123 115 24 46
CLONIDINE HCL 116 112 25 60
ENALAPRIL MALEATE 112 98 26 68
ALENDRONATE SODIUM 109 105 27 25
PREDNISONE 101 100 28 36
METOPROLOL TARTRATE 101 101 28 9
OXYBUTYNIN CHLORIDE 101 95 28 96
CARVEDILOL 96 90 31 21
CRESTOR 91 79 32 27
FLUOXETINE HCL 90 88 33 45
GLIMEPIRIDE 88 69 34 34
EVISTA 88 88 34 92
ZOLPIDEM TARTRATE 85 77 36 23
CLOPIDOGREL 84 74 37 29
LOSARTAN POTASSIUM 82 78 38 18
PROPRANOLOL HCL 81 70 39 129
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 78 40 33
VERAPAMIL ER 75 60 41 119
TAMSULOSIN HCL 73 67 42 26
CARBIDOPA-LEVODOPA 73 72 42 88
DOXAZOSIN MESYLATE 72 63 44 87
TRIAMCINOLONE ACETONIDE 70 61 45 151
GLYBURIDE 67 54 R 46 111
BUSPIRONE HCL 67 56 46 124
LOVAZA 66 62 48 163
KLOR-CON 10 65 42 49 102
MIRTAZAPINE 65 64 49 52
BENAZEPRIL HCL 62 62 51 85
NABUMETONE 61 49 52 178
AMOXICILLIN 61 55 52 116
PREMARIN 57 57 R 54 176
SPIRONOLACTONE 55 46 55 57
KLOR-CON M20 54 47 56 48
ALLOPURINOL 53 50 57 31
CHLORTHALIDONE 53 36 57 143
ADVAIR DISKUS 53 50 57 50
ISOSORBIDE MONONITRATE ER 52 51 60 40
SPIRIVA 51 46 61 59
PROAIR HFA 50 49 62 56
ACTONEL 50 50 62 224
LORAZEPAM 50 36 62 306
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.